Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
9.53
+0.08 (0.85%)
Jul 3, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $24.08 | Buy | Initiates | $24.08 | +152.65% | Jun 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26.91 | Buy | Maintains | $26.91 | +182.37% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $35.41 | Buy | Initiates | $35.41 | +271.54% | May 20, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.66 | Buy | Maintains | $22.66 | +137.78% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.58 | Buy | Reiterates | $15.58 | +63.48% | May 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $19.83 | Buy | Reiterates | $19.83 | +108.06% | May 5, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.83 | Buy | Maintains | $19.83 | +108.06% | Apr 28, 2026 |